我的生活+的主要目标之一是帮助人们预防新的HIV和其他STI，丙型肝炎和结核病病历的产生。

该应用程序有助于建立医生和HIV感染者之间的匿名沟通。它可以让您创建简单易行的服药时间表，并设置隐藏和个性化的提醒。

全部新闻 / 十月 2018

归档

✕

19 十月 2018

7641

Gilead and Aelix join forces to develop a promising anti-HIV combination

Gilead and Aelix join forces to develop a promising anti-HIV combination

American pharmaceutical company Gilead Sciences - the world leader in the development of drugs for the treatment of HIV and hepatitis C - has teamed up with the Spanish Aelix Therapeutics in order to develop a fundamentally new ART-regimen, according to PMLive.

18 十月 2018

7830

IDWeek-2018 presented new data confirming the long-term effectiveness of ART-schemes “in one pill”

IDWeek-2018 presented new data confirming the long-term effectiveness of ART-schemes “in one pill”

According to a number of studies presented at the IDWeek-2018 conference in San Francisco, several newest ART-schemes “in one pill” are capable of supporting an undetectable burden of HIV for two years or more.

17 十月 2018

6515

Spanish scientists told about promising results of HIV suppression in stem cell transplantation

Spanish scientists told about promising results of HIV suppression in stem cell transplantation

A group of researchers from the Madrid Hospital. Gregorio Maranyon and the IrsiCaixa HIV Research Institute of Barcelona last Tuesday reported on the impressive results of suppressing HIV-positive patients with virus strains in hidden reservoirs thanks to the stem cell transplant ...

15 十月 2018

5982

American patients admitted that they are not ready to switch to new ways of ART delivery

American patients admitted that they are not ready to switch to new ways of ART delivery

According to a US study published in Open Forum Infectious Diseases, two-thirds of people taking combined antiretroviral therapy (ART) will be interested in switching to the oral regimen once a week. The idea of switching to long-term injection therapy is supported by less ...